Discover
BMRN
BioMarin Pharmaceutical Inc.
57.82
1 x 55.44
1 x 60.47
bid
ask
+
0.60
1.05%
1 @ 04:01 AM
57.94 +0.12 (0.21%)
| Ytd | -2.71% | |
| 1y | 2.90% |
57.25
day range
58.56
49.26
52 week range
66.28
| Open | 57.59 | Prev Close | 57.22 | Low | 57.25 | High | 58.56 | Mkt Cap | 11.18B |
| Vol | 1.46M | Avg Vol | 2.07M | EPS | 1.39 | P/E | 41.60 | Forward P/E | 8.95 |
| Beta | 0.24 | Short Ratio | 5.06 | Inst. Own | 102.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-03 | 50-d Avg | 54.63 | 200-d Avg | 55.71 | 1yr Est | 87.85 |
| Income Statement | |||
| Total Revenue | 766.21M | ||
| Revenues (USD) | 766.21M | ||
| Cost of Revenue | 195.00M | ||
| Gross Profit | 571.21M | ||
| Operating Expenses | 441.57M | ||
| Research and Development Expense | 178.80M | ||
| Selling, General and Administrative Expense | 258.29M | ||
| Operating Income | 129.64M | ||
| Interest Expense | 14.96M | ||
| Income Tax Expense | 35.68M | ||
| Net Income | 105.53M | ||
| Net Income Common Stock | 105.53M | ||
| Net Income Common Stock (USD) | 105.53M | ||
| Consolidated Income | 105.53M | ||
| Earnings per Basic Share | 0.55 | ||
| Earnings per Basic Share (USD) | 0.55 | ||
| Earnings per Diluted Share | 0.54 | ||
| Earning Before Interest & Taxes (EBIT) | 156.16M | ||
| Earning Before Interest & Taxes (USD) | 156.16M | ||
| Weighted Average Shares | 192.50M | ||
| Weighted Average Shares Diluted | 197.67M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.07B | ||
| Cash and Equivalents (USD) | 3.07B | ||
| Trade and Non-Trade Receivables | 903.91M | ||
| Current Assets | 4.61B | ||
| Property, Plant & Equipment Net | 958.07M | ||
| Total Assets | 8.59B | ||
| Total Debt | 1.43B | ||
| Current Liabilities | 793.15M | ||
| Debt Non-Current | 1.43B | ||
| Total Liabilities | 2.38B | ||
| Accumulated Retained Earnings (Deficit) | 259.73M | ||
| Accumulated Other Comprehensive Income | -4.24M | ||
| Shareholders Equity | 6.21B | ||
| Shareholders Equity (USD) | 6.21B | ||
| Assets Non-Current | 3.99B | ||
| Total Debt (USD) | 1.43B | ||
| Goodwill and Intangible Assets | 400.86M | ||
| Inventory | 1.27B | ||
| Liabilities Non-Current | 1.59B | ||
| Trade and Non-Trade Payables | 793.15M | ||
| Tax Assets | 1.50B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 16.41M | ||
| Net Cash Flow from Financing | 813.17M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.76B | ||
| Capital Expenditure | -20.92M | ||
| Issuance (Repayment) of Debt Securities | 841.35M | ||
| Net Cash Flow from Investing | 725.53M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 741.49M | ||
| Net Cash Flow from Operations | 220.65M | ||
| Effect of Exchange Rate Changes on Cash | 1.41M | ||
| Share Based Compensation | 43.46M | ||